NCT04002414

Brief Summary

Randomized control trial to determine if performing the US Health and Human Services recommended amount of weekly physical activity during ovarian stimulation will differentially affect mental health or clinical outcomes of individuals who are usually active, insufficiently active, or inactive in their everyday lives. The goal overall is to assess for safety and value of physical activity during fertility treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
215

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 26, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 28, 2019

Completed
11 months until next milestone

Study Start

First participant enrolled

May 15, 2020

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2023

Completed
Last Updated

December 27, 2023

Status Verified

December 1, 2023

Enrollment Period

3.3 years

First QC Date

June 26, 2019

Last Update Submit

December 20, 2023

Conditions

Keywords

Physical ActivityIn Vitro FertilizationOvarian StimulationExercise

Outcome Measures

Primary Outcomes (3)

  • Stress During Treatment based on daily end of day stress item

    As validated in prior studies (Schliep et al. 2015) examining stress and infertility, we will ask participants, "how did your stress levels today compare to your usual level of stress?" Participants will respond on a 3-point scale with the following options: 1 (not stressful), 2 (a little stressful), 3 (very stressful). We plan to compare average daily stress as well as stress trend over the 14-days of stimulation.

    14 days

  • Anxiety/Depression During Treatment based on Patient-Reported Outcomes Measurement Information System Short Form (PROMIS-SF) Depression 4a and Anxiety 4a

    Measured with daily PROMIS-SF Depression 4a and Anxiety 4a questions for the approximately two weeks of ovarian stimulation. The PROMIS-SF Anxiety 4a item bank assesses self-reported fear, anxious misery, hyperarousal, and arousal-related somatic symptoms (e.g., dizziness). The PROMIS-SF Depression 4a item bank assesses self-reported negative mood (e.g., sadness), views of self (e.g., worthlessness), social cognition (e.g., loneliness), and decreased positive affect and engagement. Items are all answered on a 5-point scale from 1=Never to 5=Always. Scores can range from 0 meaning no anxiety/depression to 40 meaning high anxiety/depression.

    14 days

  • Change in Stress during treatment based upon Perceived Stress Scale (PSS)-14

    Change in mean PSS-14 score from pre-treatment to post-treatment. PSS-14 includes 14 items, 7 negatively states items and 7 positively stated items. Each item is rated on a 5-point scale (0 = Never, 1 = Almost Never, 2 = Sometimes, 3 = Fairly Often, 4 = Very Often). The positively stated items re reverse coded, so all items are summed to create a total score. Scores can range from 0 meaning no stress to 56 meaning severely stressed.

    4 weeks

Secondary Outcomes (8)

  • Number of mature oocytes retrieved

    4 weeks

  • Fertilization Rate

    4 weeks

  • Blastulation Rate

    4 weeks

  • Clinical Pregnancy Rate

    6 weeks

  • Cancellation Rate

    2 weeks

  • +3 more secondary outcomes

Study Arms (4)

Usually Active- Decrease

ACTIVE COMPARATOR

Participants who usually meet or exceed recommended levels of physical activity who will be asked to minimize activity during stimulation.

Behavioral: Insufficient physical activity

Usually Active- Maintenance

EXPERIMENTAL

Participants who usually meet or exceed recommended levels of physical activity who will be asked to maintain usual level of activity during stimulation.

Behavioral: Sufficient physical activity

Usually Insufficiently Inactive- Increase

EXPERIMENTAL

Participants who are usually inactive who will be asked to try to increase activity to the recommended level during stimulation.

Behavioral: Sufficient physical activity

Usually Insufficiently Inactive- Maintenance

ACTIVE COMPARATOR

Participants who are usually inactive who will be asked to maintain inactivity during stimulation.

Behavioral: Insufficient physical activity

Interventions

Physical activity at the recommended levels by the US Health and Human Services Department: 75 minutes a week of vigorous activity or 150 minutes a week of moderate activity.

Usually Active- MaintenanceUsually Insufficiently Inactive- Increase

Physical activity less than the recommended levels by the US Health and Human Services Department: 75 minutes a week of vigorous activity or 150 minutes a week of moderate activity.

Usually Active- DecreaseUsually Insufficiently Inactive- Maintenance

Eligibility Criteria

Age18 Years - 43 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • First ovarian stimulation cycle for egg freezing or for in vitro fertilization
  • English speaking/reading
  • Patient at the Center for Reproductive Health, University of California San Francisco

You may not qualify if:

  • Serious health conditions that limit amount of physical activity
  • BMI\>40

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCSF Medical Center at Mission Bay

San Francisco, California, 94158, United States

Location

MeSH Terms

Conditions

Infertility, FemaleMotor Activity

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesInfertilityBehavior

Study Officials

  • Heather Huddleston, MD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients will be stratified into groups: "active" or "insufficiently active" based on current average physical activity. Randomization will be into one of two parallel arms, maintenance of current activity during ovarian stimulation, or modify activity level during ovarian stimulation.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 26, 2019

First Posted

June 28, 2019

Study Start

May 15, 2020

Primary Completion

September 1, 2023

Study Completion

September 1, 2023

Last Updated

December 27, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations